Trump’s weapon lurks in abandoned America

Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…

RVMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,920,225.17

Revolution Medicines Insider Trading History Chart

Revolution Medicines Share Price & Price History

^$44.06

▲ +0.29 (0.66%)

As of 09/18/2024 01:00 AM ET

Days: 30 | 90 | 365

Central Bank Abandons USD

From True Gold Republic | Ad

Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.

Click here now to get your free 'Protect Your Wealth' Guide.

Revolution Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$45.88	$458,800.00	311,885
7/15/2024	Stephen Michael Kelsey	Insider	Sell	16,667	$46.47	$774,515.49	269,073
7/12/2024	Mark A. Goldsmith	Insider	Sell	25,000	$45.05	$1,126,250.00	311,885
7/9/2024	Jeff Cislini	General Counsel	Sell	2,399	$40.83	$97,951.17	47,088
7/9/2024	Sushil Patel	Director	Sell	2,155	$44.00	$94,820.00	19,948
6/26/2024	Jeff Cislini	General Counsel	Sell	2,000	$38.47	$76,940.00	49,487
6/24/2024	Stephen Michael Kelsey	Insider	Sell	200	$39.00	$7,800.00	269,073
5/3/2024	Jack Anders	CFO	Sell	10,000	$40.03	$400,300.00	101,959
4/10/2024	Mark A. Goldsmith	Insider	Sell	7,500	$35.48	$266,100.00	452,879
4/10/2024	Sushil Patel	Director	Sell	2,155	$37.00	$79,735.00	15,700
3/27/2024	Jeff Cislini	General Counsel	Sell	1,500	$30.99	$46,485.00	54,374
3/18/2024	Jack Anders	CFO	Sell	1,261	$31.58	$39,822.38	101,959
3/18/2024	Jeff Cislini	General Counsel	Sell	1,252	$31.58	$39,538.16	55,874
3/18/2024	Margaret A. Horn	COO	Sell	2,914	$31.58	$92,024.12	139,553
3/18/2024	Stephen Michael Kelsey	Insider	Sell	2,123	$31.58	$67,044.34	270,909
1/22/2024	Jeff Cislini	General Counsel	Sell	1,500	$27.00	$40,500.00	36,126
1/8/2024	Stephen Michael Kelsey	Insider	Sell	3,337	$29.01	$96,806.37	221,632
12/27/2023	Stephen Michael Kelsey	Insider	Sell	33,334	$29.01	$967,019.34	238,299
12/18/2023	Jack Anders	CFO	Sell	1,775	$25.90	$45,972.50	76,416
12/18/2023	Jeff Cislini	General Counsel	Sell	1,229	$25.90	$31,831.10	37,284
12/18/2023	Margaret A. Horn	COO	Sell	2,993	$25.90	$77,518.70	101,467
12/18/2023	Mark A. Goldsmith	Insider	Sell	8,165	$25.90	$211,473.50	376,167
12/15/2023	Margaret A. Horn	COO	Sell	5,000	$26.64	$133,200.00	104,460
11/20/2023	Jeff Cislini	General Counsel	Sell	1,500	$21.70	$32,550.00	38,513
10/16/2023	Margaret A. Horn	COO	Sell	25,000	$33.95	$848,750.00	96,960
10/11/2023	Stephen Michael Kelsey	Insider	Sell	16,667	$29.05	$484,176.35	273,721
9/28/2023	Jeff Cislini	General Counsel	Sell	2,000	$28.20	$56,400.00	40,013
9/18/2023	Jack Anders	CFO	Sell	1,427	$31.31	$44,679.37	53,667
9/18/2023	Jeff Cislini	General Counsel	Sell	1,214	$31.31	$38,010.34	42,013
9/18/2023	Margaret A. Horn	COO	Sell	2,514	$31.31	$78,713.34	96,960
9/18/2023	Stephen Michael Kelsey	Insider	Sell	2,060	$31.31	$64,498.60	290,388
9/15/2023	Margaret A. Horn	COO	Sell	5,000	$32.08	$160,400.00	99,474
9/1/2023	Barbara Weber	Director	Sell	15,000	$35.07	$526,050.00	15,825
9/1/2023	Jack Anders	CFO	Sell	20,000	$35.05	$701,000.00	55,094
9/1/2023	Mark A. Goldsmith	Insider	Sell	30,000	$35.05	$1,051,500.00	357,386
8/31/2023	Margaret A. Horn	COO	Sell	10,000	$34.05	$340,500.00	99,474
8/15/2023	Margaret A. Horn	COO	Sell	5,000	$30.53	$152,650.00	99,474
8/1/2023	Stephen Michael Kelsey	Insider	Sell	16,666	$29.19	$486,480.54	309,114
7/31/2023	Jeff Cislini	General Counsel	Sell	1,500	$26.02	$39,030.00	43,227
6/20/2023	Jack Anders	CFO	Sell	1,249	$24.89	$31,087.61	55,094
6/20/2023	Jeff Cislini	General Counsel	Sell	1,239	$25.14	$31,148.46	44,727
6/20/2023	Stephen Michael Kelsey	Insider	Sell	2,102	$24.89	$52,318.78	325,780
3/17/2023	Jack Anders	CFO	Sell	665	$21.78	$14,483.70	55,233
3/17/2023	Margaret A. Horn	Insider	Sell	1,230	$21.78	$26,789.40	100,062
3/10/2023	Thilo Schroeder	Director	Buy	100,000	$20.46	$2,046,000.00	1,553,134
3/7/2023	Thilo Schroeder	Director	Buy	550,000	$22.00	$12,100,000.00	1,453,134
12/19/2022	Jack Anders	CFO	Sell	658	$22.94	$15,094.52	29,298
12/19/2022	Xiaolin Wang	Insider	Sell	708	$22.94	$16,241.52	30,527
10/31/2022	Margaret A. Horn	COO	Sell	17,767	$20.41	$362,624.47	17,767
10/26/2022	Margaret A. Horn	Insider	Sell	17,768	$20.15	$358,025.20	35,534
9/19/2022	Jack Anders	CFO	Sell	449	$19.04	$8,548.96	29,956
9/19/2022	Xiaolin Wang	Insider	Sell	735	$19.04	$13,994.40	31,235
7/22/2022	Lorence H. Kim	Director	Buy	50,000	$20.00	$1,000,000.00	60,500
6/17/2022	Xiaolin Wang	Insider	Sell	665	$17.75	$11,803.75	31,970
6/8/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	419,901	$20.25	$8,502,995.25	5,104,130
3/28/2022	Thilo Schroeder	Director	Buy	725	$24.71	$17,914.75
3/25/2022	Thilo Schroeder	Director	Buy	42,000	$24.79	$1,041,180.00
3/23/2022	Thilo Schroeder	Director	Buy	53,118	$23.72	$1,259,958.96
3/21/2022	Thilo Schroeder	Director	Buy	75,731	$20.74	$1,570,660.94
3/18/2022	Thilo Schroeder	Director	Buy	82,200	$20.30	$1,668,660.00
3/17/2022	Margaret A. Horn	Insider	Sell	321	$18.61	$5,973.81
3/11/2022	Thilo Schroeder	Director	Buy	3,110	$20.93	$65,092.30
3/9/2022	Thilo Schroeder	Director	Buy	39,600	$20.07	$794,772.00
3/7/2022	Thilo Schroeder	Director	Buy	103,005	$18.39	$1,894,261.95
3/4/2022	Thilo Schroeder	Director	Buy	56,300	$17.69	$995,947.00
3/2/2022	Thilo Schroeder	Director	Buy	116,290	$18.94	$2,202,532.60
2/18/2022	Thilo Schroeder	Director	Buy	400,000	$17.00	$6,800,000.00
2/8/2022	Thilo Schroeder	Director	Buy	300,000	$45.00	$13,500,000.00
12/17/2021	Jack Anders	Insider	Sell	170	$24.41	$4,149.70
9/17/2021	Jack Anders	Insider	Sell	166	$30.02	$4,983.32

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

SEC Filings (Institutional Ownership Changes) for Revolution Medicines (NASDAQ:RVMD)

94.34% of Revolution Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revolution Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/16/2024	Point72 Asia Singapore Pte. Ltd.	5,966	$0.23M	0.0%	N/A	0.004%
8/26/2024	Teachers Retirement System of The State of Kentucky	31,410	$1.22M	0.0%	-16.0%	0.019%
8/19/2024	Point72 Asset Management L.P.	227,922	$8.85M	0.0%	N/A	0.136%
8/16/2024	Creative Planning	27,029	$1.05M	0.0%	+65.2%	0.016%
8/16/2024	Algert Global LLC	40,048	$1.55M	0.1%	+519.9%	0.024%
8/15/2024	Susquehanna Fundamental Investments LLC	228,513	$8.87M	0.2%	+10.7%	0.137%
8/15/2024	The Manufacturers Life Insurance Company	212,368	$8.24M	0.0%	+6.7%	0.127%
8/15/2024	AQR Capital Management LLC	12,832	$0.50M	0.0%	N/A	0.008%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	5,966	$0.23M	0.0%	N/A	0.004%
8/14/2024	Fred Alger Management LLC	21,764	$0.85M	0.0%	N/A	0.013%
8/14/2024	Marshall Wace LLP	816,055	$31.67M	0.0%	-46.9%	0.489%
8/14/2024	Logos Global Management LP	1,200,000	$46.57M	3.7%	N/A	0.727%
8/14/2024	Farallon Capital Management LLC	9,757,692	$378.70M	1.8%	+30.0%	5.842%
8/14/2024	Xponance Inc.	9,651	$0.38M	0.0%	+13.9%	0.006%
8/14/2024	Integral Health Asset Management LLC	325,000	$12.61M	1.2%	-22.6%	0.195%
8/14/2024	Hood River Capital Management LLC	914,003	$35.47M	0.7%	N/A	0.547%
8/14/2024	HighVista Strategies LLC	40,083	$1.56M	0.6%	+179.8%	0.024%
8/14/2024	ProShare Advisors LLC	28,868	$1.12M	0.0%	-21.1%	0.017%
8/14/2024	Profund Advisors LLC	35,999	$1.40M	0.1%	-21.9%	0.022%
8/13/2024	Ensign Peak Advisors Inc	269,504	$10.46M	0.0%	+577.4%	0.163%
8/13/2024	Sei Investments Co.	45,149	$1.75M	0.0%	+175.8%	0.027%
8/13/2024	Public Employees Retirement Association of Colorado	13,423	$0.52M	0.0%	-1.9%	0.008%
8/12/2024	XTX Topco Ltd	23,717	$0.92M	0.1%	N/A	0.014%
8/12/2024	Seven Eight Capital LP	69,602	$2.70M	0.3%	+1.6%	0.042%
8/12/2024	Hsbc Holdings PLC	14,913	$0.57M	0.0%	-91.1%	0.009%
8/12/2024	Amalgamated Bank	5,272	$0.21M	0.0%	+7.4%	0.003%
8/12/2024	E Fund Management Co. Ltd.	11,274	$0.44M	0.0%	-16.1%	0.007%
8/10/2024	Sofinnova Investments Inc.	455,099	$17.66M	0.9%	N/A	0.276%
8/9/2024	Citizens Financial Group Inc. RI	28,562	$1.11M	0.0%	N/A	0.017%
8/9/2024	Dimensional Fund Advisors LP	390,583	$15.16M	0.0%	-70.7%	0.237%
8/8/2024	First Turn Management LLC	329,519	$12.79M	2.1%	N/A	0.200%
8/8/2024	Nicholas Investment Partners LP	158,132	$6.14M	0.6%	N/A	0.096%
8/8/2024	American Century Companies Inc.	519,305	$20.15M	0.0%	N/A	0.315%
8/8/2024	State of New Jersey Common Pension Fund D	51,045	$1.98M	0.0%	-44.4%	0.031%
8/6/2024	Great Lakes Advisors LLC	120,867	$4.69M	0.0%	-58.2%	0.073%
8/6/2024	Los Angeles Capital Management LLC	7,451	$0.29M	0.0%	-17.4%	0.005%
8/6/2024	Candriam S.C.A.	554,334	$21.51M	0.1%	-5.1%	0.336%
8/5/2024	Arizona State Retirement System	32,273	$1.25M	0.0%	+15.6%	0.020%
8/5/2024	Victory Capital Management Inc.	542,601	$21.06M	0.0%	-9.7%	0.329%
8/3/2024	TD Asset Management Inc	250,194	$9.71M	0.0%	-1.7%	0.152%
8/2/2024	Alphabet Inc.	5,307,075	$205.97M	10.4%	+0.1%	3.217%
8/1/2024	Rhumbline Advisers	228,567	$8.87M	0.0%	+9.2%	0.139%
7/29/2024	Principal Financial Group Inc.	24,222	$0.94M	0.0%	-19.9%	0.015%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	24,562	$0.95M	0.0%	+48.2%	0.015%
7/26/2024	Legato Capital Management LLC	20,199	$0.78M	0.1%	N/A	0.012%
7/26/2024	Bank of New York Mellon Corp	645,253	$25.04M	0.0%	+21.9%	0.391%
7/20/2024	China Universal Asset Management Co. Ltd.	19,383	$0.75M	0.1%	-38.7%	0.012%
7/20/2024	Nisa Investment Advisors LLC	3,378	$0.13M	0.0%	+10.5%	0.002%
7/19/2024	Raymond James & Associates	74,370	$2.89M	0.0%	+196.4%	0.045%
7/17/2024	Clear Harbor Asset Management LLC	11,224	$0.44M	0.0%	+10.2%	0.007%
7/12/2024	SG Americas Securities LLC	10,730	$0.42M	0.0%	+17.5%	0.007%
5/28/2024	Teachers Retirement System of The State of Kentucky	37,377	$1.21M	0.0%	-6.0%	0.023%
5/24/2024	Farallon Capital Management LLC	7,507,872	$241.98M	1.1%	+11.4%	4.551%
5/17/2024	Artal Group S.A.	1,318,649	$42.50M	1.1%	-22.2%	0.799%
5/16/2024	California State Teachers Retirement System	105,373	$3.40M	0.0%	-7.7%	0.064%
5/16/2024	Janus Henderson Group PLC	3,912,119	$126.07M	0.1%	+77.9%	2.371%
5/16/2024	Bayesian Capital Management LP	10,500	$0.34M	0.0%	N/A	0.006%
5/16/2024	Paloma Partners Management Co	11,545	$0.37M	0.0%	N/A	0.007%
5/15/2024	Baker BROS. Advisors LP	7,549,249	$243.31M	3.1%	+46.6%	4.576%
5/15/2024	Bellevue Group AG	5,073,600	$163.52M	2.5%	-0.3%	3.075%
5/15/2024	Price T Rowe Associates Inc. MD	4,814,310	$155.17M	0.0%	+3.8%	2.918%
5/14/2024	Nan Fung Group Holdings Ltd	7,300	$0.24M	0.2%	N/A	0.004%
5/14/2024	EntryPoint Capital LLC	3,335	$0.11M	0.1%	N/A	0.002%
5/14/2024	Natixis	6,075	$0.20M	0.0%	N/A	0.004%
5/14/2024	CANADA LIFE ASSURANCE Co	15,646	$0.50M	0.0%	+74.8%	0.009%
5/14/2024	American International Group Inc.	68,744	$2.22M	0.0%	-3.8%	0.042%
5/13/2024	Seven Eight Capital LP	68,494	$2.21M	0.2%	N/A	0.042%
5/13/2024	Ameritas Investment Partners Inc.	13,911	$0.45M	0.0%	-6.6%	0.008%
5/10/2024	Vanguard Group Inc.	14,757,112	$475.62M	0.0%	+0.8%	8.656%
5/9/2024	State Board of Administration of Florida Retirement System	20,225	$0.65M	0.0%	-48.2%	0.012%
5/8/2024	ProShare Advisors LLC	36,605	$1.18M	0.0%	+6.8%	0.021%
5/8/2024	Headlands Technologies LLC	1,513	$49K	0.0%	+140.9%	0.001%
5/7/2024	Sei Investments Co.	16,371	$0.53M	0.0%	N/A	0.010%
5/7/2024	Susquehanna Fundamental Investments LLC	206,513	$6.66M	0.3%	N/A	0.121%
5/7/2024	SG Americas Securities LLC	9,129	$0.29M	0.0%	+153.9%	0.005%
5/6/2024	Duality Advisers LP	25,623	$0.83M	0.1%	N/A	0.015%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	51,059	$1.65M	0.0%	-36.5%	0.030%
4/30/2024	Allspring Global Investments Holdings LLC	3,218	$0.10M	0.0%	N/A	0.002%
4/29/2024	China Universal Asset Management Co. Ltd.	31,637	$1.02M	0.1%	+67.0%	0.019%
4/18/2024	Allspring Global Investments Holdings LLC	3,218	$0.10M	0.0%	N/A	0.002%
4/4/2024	Mass General Brigham Inc	338,191	$10.90M	19.1%	N/A	0.205%
3/11/2024	Vanguard Group Inc.	14,634,391	$419.71M	0.0%	+51.8%	8.886%
3/5/2024	Mubadala Investment Co PJSC	278,000	$7.97M	0.0%	N/A	0.169%
3/5/2024	Wellington Management Group LLP	14,882,086	$426.82M	0.1%	+40.8%	9.036%
3/1/2024	Goldman Sachs Group Inc.	1,053,257	$30.21M	0.0%	+67.9%	0.961%
2/28/2024	American International Group Inc.	71,494	$2.05M	0.0%	+41.3%	0.065%
2/26/2024	Perceptive Advisors LLC	818,882	$23.49M	0.5%	-38.0%	0.747%
2/16/2024	Price T Rowe Associates Inc. MD	4,636,353	$132.97M	0.0%	-9.0%	4.231%
2/15/2024	BVF Inc. IL	5,981,212	$171.54M	4.3%	+50.2%	5.459%
2/15/2024	Boxer Capital LLC	4,279,464	$122.74M	6.1%	-8.6%	3.906%
2/14/2024	Avidity Partners Management LP	60,000	$1.72M	0.1%	-90.9%	0.055%
2/14/2024	Bellevue Group AG	5,091,000	$146.01M	2.2%	+7.8%	4.646%
2/14/2024	Pale Fire Capital SE	11,142	$0.32M	0.0%	N/A	0.010%
2/14/2024	Vestal Point Capital LP	725,000	$20.79M	2.2%	N/A	0.662%
2/14/2024	Sectoral Asset Management Inc.	13,710	$0.39M	0.2%	-90.4%	0.013%
2/13/2024	Bain Capital Life Sciences Investors LLC	1,112,396	$31.90M	3.1%	N/A	1.015%
2/13/2024	Rafferty Asset Management LLC	365,095	$10.47M	0.0%	+60.9%	0.333%
2/13/2024	NEOS Investment Management LLC	10,904	$0.31M	0.0%	N/A	0.010%
2/13/2024	Finepoint Capital LP	617,100	$17.70M	5.0%	+44.5%	0.563%
2/9/2024	UBS Group AG	306,558	$8.79M	0.0%	+215.5%	0.280%

Data available starting January 2016

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $44.06

$43.48

$45.26

50 Day Range

MA: $43.92

$41.56

$47.94

52 Week Range

Now: $44.06

$15.44

$48.61

Volume

881,433 shs

Average Volume

1,327,452 shs

Market Capitalization

$7.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43

Who are the company insiders with the largest holdings of Revolution Medicines?: Revolution Medicines' top insider shareholders include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Margaret A Horn (Insider)
Jeff Cislini (General Counsel)
Xiaolin Wang (Insider)
Sushil Patel (Director)
Barbara Weber (Director)
Learn More about top insider investors at Revolution Medicines.
Who are the major institutional investors of Revolution Medicines?: Revolution Medicines' top institutional investors include:
Farallon Capital Management LLC — 5.84%
Alphabet Inc. — 3.22%
Logos Global Management LP — 0.73%
Hood River Capital Management LLC — 0.55%
Marshall Wace LLP — 0.49%
Bank of New York Mellon Corp — 0.39%
Learn More about top institutional investors of Revolution Medicines stock.
Which institutional investors are selling Revolution Medicines stock?: Within the last quarter, RVMD stock was sold by these institutional investors:
Dimensional Fund Advisors LP
Marshall Wace LLP
Great Lakes Advisors LLC
Hsbc Holdings PLC
Integral Health Asset Management LLC
Victory Capital Management Inc.
State of New Jersey Common Pension Fund D
Candriam S.C.A.
In the last year, company insiders that have sold Revolution Medicines company stock include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Margaret A Horn (Insider)
Learn More investors selling Revolution Medicines stock.
Which institutional investors are buying Revolution Medicines stock?: In the last quarter, RVMD stock was purchased by institutional investors including:
Farallon Capital Management LLC
Logos Global Management LP
Hood River Capital Management LLC
American Century Companies Inc.
Sofinnova Investments Inc.
First Turn Management LLC
Ensign Peak Advisors Inc
Point72 Asset Management L.P.